Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

2(33.3%)

6Total

N/A(4)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03740022Not ApplicableCompleted

ACL Versus ALL + ACL Study

Role: lead

NCT01728532Not ApplicableCompleted

Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer

Role: lead

NCT02361242Phase 2Completed

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion

Role: collaborator

NCT02361424Phase 2Completed

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

Role: collaborator

NCT01737229Not ApplicableCompleted

Efficacy and the Safety Study of RD94 in Patients With Endodontic Care

Role: lead

NCT01175200Not ApplicableCompleted

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.

Role: lead

All 6 trials loaded